Increasing human papillomavirus vaccination at the recommended age

An age-structured model of human papillomavirus vaccination

Recently, a vaccine for human papillomavirus was introduced, but made available only for girls and adult women aged 13–26. ince rates of sexual activity vary by age and gender, vaccinating only an age-limited subset of one cohort may be insufficient to ontrol the disease across all age groups and genders. We develop an age-dependent two-sex mathematical model to describe the PV vaccination prog...

Vaccination against human papillomavirus

Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.

Human papillomavirus vaccination.

Human Papillomavirus Vaccination Strategies

with no adverse effects reported. One patient treated herself with albendazole (400 mg/day for 3 days) before she was seen at a hospital. All patients became asymptomatic and had negative stool examination results 2–10 weeks after treatment. None of the patients reported previous or subsequent consumption of raw freshwater fi sh. Raw fi sh preparations such as sushi, sashimi, carpaccio, and cev...

Preventive human papillomavirus vaccination.